Ads
related to: amdautometaldirect.com has been visited by 10K+ users in the past month
Search results
AMD's AI Ambitions: 3 Reasons to Buy the Dip Despite China's Chip Ban
InvestorPlace· 2 hours agoGraphics chip and CPU designer Advanced Micro Devices (NASDAQ:AMD) stock has had a tough several...
Smart Money Is Betting Big In AMD Options - Advanced Micro Devices (NASDAQ:AMD)
Benzinga· 2 hours agoLoading... Loading... Financial giants have made a conspicuous bearish move on Advanced Micro Devices. Our analysis of options history for Advanced Micro Devices AMD revealed ...
AMD Working on Ryzen 5000XT CPU Refresh
Game Rant· 22 hours agoAMD is not abandoning the AM4 socket yet, as sources claim that the tech giant is working on a Ryzen 5000XT refresh for its last-gen CPU lineup. This...
Lenovo says demand for AMD's Instinct MI300 is record high — plans to offer AI solutions from all...
Tom s Hardware· 5 hours agoDemand for AMD Instinct MI300-series-based machines is apparently setting records, at least at...
RNC Capital Management LLC Increases Position in Advanced Micro Devices, Inc. (NASDAQ:AMD)
ETF DAILY NEWS· 8 hours agoRNC Capital Management LLC boosted its holdings in shares of Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) by 64.1% in the 4th quarter, according to the company ...
Ignore the Noise: 3 Reasons Why AMD Stock's AI-Powered Bull Case Remains Intact
InvestorPlace· 1 day agoAfter climbing to prices topping $225 per share, Advanced Micro Devices (NASDAQ:AMD) stock has slid...
Standardization opens door to 3rd-party dies in AMD designs
The Register· 16 hours agoVideo Future AMD processors could feature domain-specific accelerators – even some created by third...
With 72% institutional ownership, Advanced Micro Devices, Inc. (NASDAQ:AMD) is a favorite amongst...
Simply Wall St. via Yahoo Finance· 1 day ago(NASDAQ:AMD), it is important to understand the ownership structure of the business. And the group...
4 Reasons to Buy AMD Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 2 days agoAdvanced Micro Devices (NASDAQ: AMD) became a favorite on Wall Street last year when a boom in artificial intelligence (AI) highlighted the massive...
REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time...
Morningstar· 4 hours agoREGENXBIO Inc. (Nasdaq: RGNX) today announced the publication of results from the Phase I/IIa trial evaluating the safety and tolerability of a single dose of subretinal ABBV-RGX-314 for the ...